STX Shield Therapeutics plc

0.0402USD3.050 GBp · LSE0.00%Mkt Cap: 43.14M USDP/E: —

Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Fera…